-
News | 2018.04.11
New Pasteur-USP Scientific Platform in Brazil to tackle neurological disorders with a one health approach
A group of scientists are in the process of setting up the first crew of a research taskforce in Brazil, spawn of the University of São Paulo/Institut Pasteur /Fiocruz tripartite agreement signed in 2015. This scientific platform will focus on neurological disorders caused by either infectious agents or as a consequence of degenerative/progressive diseases. Both causes are growing problems in...
-
News | 2018.04.17
Aedes aegypti mosquitoes’ gut microbiota is environmentally determined
For many years, microbiota – all the microorganisms that colonize a host - has been the subject of intensive research in many multicellular organisms. The mosquito Aedes aegypti vector of pathogens responsible for diseases such as dengue or yellow fever, is no exception to this rule. Recent scientific work has shown that the bacteria colonizing the mosquitoe’s digestive tract play a role in their...
-
News | 2018.04.18
Genomics study in Africa: demographic history and deleterious mutations
Scientists from the Institut Pasteur set out to understand how the demographic changes associated with the Neolithic transition also influenced the efficacy of natural selection. By comparing the genome diversity of more than 300 individuals from groups of forest hunter-gatherers (pygmies) and farmers (Bantu-speaking peoples), from western and eastern Central Africa, they discovered that the...
-
News | 2018.04.19
The book “Institut Pasteur: Today's Research, Tomorrow's Medicine” available in US bookstores
On March 27 American booksellers released Institut Pasteur: Today's Research, Tomorrow's Medicine, the French version of which debuted in France last November, corresponding with the start of the 130th year of Institut Pasteur’s existence.This illustrated volume tells the story of 130 years of research and discoveries, all the way through to the current day with Institut Pasteur's current...
-
Page avancée | 2018.04.20
Sanofi - Institut Pasteur Awards
Sanofi, a global diversified healthcare leader, and the Institut Pasteur, an internationally renowned biomedical research centre, jointly created in 2012 the Sanofi - Institut Pasteur Awards to recognize scientists for their past or ongoing research demonstrating real scientific progress in the life sciences.
-
Report | 2018.04.23
Tackling allergies
They disrupt the lives of millions of people in France and can have extremely serious complications. More than one in every four people in Europe currently suffer from allergies, and the World Health Organization predicts that by 2050 half of all those living in industrialized countries will be affected. Allergies are caused by a deregulation of the immune system, which "overreacts" to substances...
-
News | 2018.04.18
A project to strengthen National Ethics Committees in Francophone Africa
National Ethics Committees are key actors of the research and civil society world, responsible for assessing complex situations with regard to individual rights and the general interest both in the normal course as well as in times of crisis. When a clinical trial or any research involving individual is conducted, they are responsible for ensuring that research participants are protected and...
-
Document de presse | 2018.04.25
Meningococcal meningitis: stomach pain should be seen as a warning sign
Patients with meningococcal infection generally develop symptoms including a high temperature, vomiting and a stiff neck... but they might also just have a bad stomach ache. This can be so severe that they are sometimes wrongly operated for appendicitis. Teams from the Institut Pasteur and the Department of Pediatrics at Bicêtre Hospital (AP-HP) decided to investigate the question. And the...
-
News | 2018.05.22
Tiger mosquitoes: heightened surveillance in France, from May to November 2018
On Monday April 30, 2018, the French Ministry of Health announced that it was stepping up surveillance of the tiger mosquito, Aedes albopictus, which is now present in 42 French départements – twice as many as two years ago. But just how dangerous is this mosquito, vector of diseases such as dengue, chikungunya or zika?The tiger mosquito (see What is the "tiger mosquito" (Aedes albopictus)?) is...
-
Document de presse | 2018.05.23
Dengue: investigating antibodies to identify at-risk individuals
Using an original mathematical and statistical analysis method, a team of scientists from the Institut Pasteur partnered with researchers from the United States and Thailand to analyze a Thai cohort that has long been a focus of study for dengue specialists, and obtained new information that should help identify individuals at risk of infection. By modeling changes in antibody levels after...
